Search Results - "Konomi, Juna V."

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease—An Untargeted, High Resolution Metabolomics Study by Jin, Ran, PhD, Banton, Sophia, MS, MPH, Tran, ViLinh T., PhD, Konomi, Juna V., PhD, Li, Shuzhao, PhD, Jones, Dean P., PhD, Vos, Miriam B., MD, MSPH

    Published in The Journal of pediatrics (01-05-2016)
    “…Objective To conduct an untargeted, high resolution exploration of metabolic pathways that was altered in association with hepatic steatosis in adolescents…”
    Get full text
    Journal Article
  2. 2

    Plasminogen Activator Inhibitor‐1 Predicts Quantity of Hepatic Steatosis Independent of Insulin Resistance and Body Weight by Holzberg, Jeffrey R., Jin, Ran, Le, Ngoc‐Anh, Ziegler, Thomas R., Brunt, Elizabeth M., McClain, Craig J., Konomi, Juna V., Arteel, Gavin E., Vos, Miriam B.

    “…ABSTRACT Objective: The aim of the present study was to examine the association between plasminogen activator inhibitor‐1 (PAI‐1), an acute phase protein…”
    Get full text
    Journal Article
  3. 3

    A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease by Vos, Miriam B, Jin, Ran, Konomi, Juna V, Cleeton, Rebecca, Cruz, Jessica, Karpen, Saul, Rodriguez, Dellys Soler, Frediani, Jennifer K, McCracken, Courtney, Welsh, Jean

    Published in Pilot and feasibility studies (05-06-2018)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in children, and currently, there are no FDA-approved therapies. Plasminogen…”
    Get full text
    Journal Article
  4. 4

    Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data by Arsik, Idil, Frediani, Jennifer K, Frezza, Damon, Chen, Wen, Ayer, Turgay, Keskinocak, Pinar, Jin, Ran, Konomi, Juna V, Barlow, Sarah E, Xanthakos, Stavra A, Lavine, Joel E, Vos, Miriam B

    Published in Children (Basel) (25-05-2018)
    “…Validated noninvasive biomarkers to assess treatment response in pediatric nonalcoholic fatty liver disease (NAFLD) are lacking. We aimed to validate alanine…”
    Get full text
    Journal Article
  5. 5

    Low Hepatic Tissue Copper in Pediatric Nonalcoholic Fatty Liver Disease by Mendoza, Michael, Caltharp, Shelley, Song, Ming, Collin, Lindsay, Konomi, Juna V., McClain, Craig J., Vos, Miriam B.

    “…Objective: Animal models and studies in adults have demonstrated that copper restriction increases severity of liver injury in nonalcoholic fatty liver disease…”
    Get full text
    Journal Article
  6. 6

    Performance of fibrosis prediction scores in paediatric non‐alcoholic fatty liver disease by Jackson, Jasmine A, Konomi, Juna V, Mendoza, Michael V, Krasinskas, Alyssa, Jin, Ran, Caltharp, Shelley, Mouzaki, Marialena, Vos, Miriam B

    Published in Journal of paediatrics and child health (01-02-2018)
    “…Aim Non‐alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. The phenotype of NAFLD varies widely, and non‐invasive…”
    Get full text
    Journal Article
  7. 7

    Increased atherogenic lipoprotein profile in children with non‐alcoholic steatohepatitis by Castillo‐Leon, Eduardo, Connelly, Margery A., Konomi, Juna V., Caltharp, Shelley, Cleeton, Rebecca, Vos, Miriam B.

    Published in Pediatric obesity (01-09-2020)
    “…Summary Background Non‐alcoholic fatty liver disease (NAFLD) has been shown to be an independent risk factor for cardiovascular disease. In adults, histologic…”
    Get full text
    Journal Article
  8. 8

    Low Hepatic Tissue Copper in Pediatric Non-Alcoholic Fatty Liver Disease by Mendoza, Michael, Caltharp, Shelley, Song, Ming, Collin, Lindsay, Konomi, Juna V, McClain, Craig J, Vos, Miriam B

    “…OBJECTIVE:Animal models and studies in adults have demonstrated that copper restriction increases severity of liver injury in non-alcoholic fatty liver disease…”
    Get full text
    Journal Article
  9. 9

    Zinc insufficiency mediates ethanol-induced alveolar macrophage dysfunction in the pregnant female mouse by Konomi, Juna V, Harris, Frank L, Ping, Xiao-Du, Gauthier, Theresa W, Brown, Lou Ann S

    Published in Alcohol and alcoholism (Oxford) (01-01-2015)
    “…(a) Establish the minimum number of weeks of chronic ethanol ingestion needed to perturb zinc homeostasis, (b) Examine intracellular zinc status in the…”
    Get full text
    Journal Article
  10. 10

    Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study by Cioffi, Catherine E, Welsh, Jean A, Cleeton, Rebecca L, Caltharp, Shelley A, Romero, Rene, Wulkan, Mark L, Konomi, Juna V, Frediani, Jennifer K, Vos, Miriam B

    Published in Children (Basel) (03-05-2017)
    “…Little is known regarding the subsequent course of non-alcoholic fatty liver disease (NAFLD) diagnosed in childhood. The objectives of this single-center study…”
    Get full text
    Journal Article
  11. 11
  12. 12